3Mazzaferro V,Regalia E,Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirhosis[J].New England Journal of Medicine,1996,(11):693-699.
4Lo CM,Fan ST,Liu CL. The role and limitation of living donor liver transplantation for hepatocellular carcinoma[J].Liver Transplantation,2004,(03):440.
6Rand T,Loewe C,Schoder M. Arterial emboliz at i on of unresectable hepatocellular carcinoma with use of microspheres,lipiodol,and cyanoacrylate[J].Cardiovascular and Interventional Radiology,2005,(03):313-318.
7Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma:An eastern point of view[J].Liver Transplantation,2004,(2 suppl 1):S3-S8.
8Abou-Alfa GK,Schwar tz L,R icci s. PhaseⅡst udy of soraf bnib in patients with advanced hepatocellucarcinoma[J].Journal of Clinical Oncology,2006,(06):4293-4300.
9Bertelli R,Neri F,Tsivian M. Endolymphatic immunotherapy in inoperable hepatocellular carcinoma[J].Transplantation Proceedings,2008,(06):1913-1915.
10Sun XY,Wu ZD,Hu JB. Suicide gene therapy of hepatocellular carcnoma and delivery procedure and rout e of therapeutic gene in vivo[J].Hepatobiliary & Pancreatic Diseases International,2002,(03):373-377.
7Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [J].N Engl J Med, 1996,334(11):693 - 699.
8Yao F Y, Bass N M, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma:analysis of survival according to the intention - to -treat principle and dropout from the wait-ing list [ J ]. Liver Transpl, 2002,8 ( 10 ) : 873 -883.
9chen MH, wei Y, Yan K, et al. Treatment strat- egy to opti - mize radiofrequency ablation for 1 iver malignancies. J Vasc In - terv Radiol, 2006,17:671 - 683.
10Amann T, Bataille F, Spruss T, et al. Reduced expression of fibroblast factor receptor 2 m b in hepatocellular carcinoma induces a more aggressive growth [ J ]. Am J.
1Liaw YF .Prevention and surveillance of hepatitis B[J].virus-related hep- atocellular carcinoma, 2005 ( 11 ): 120-121.
2Bolukbas C, Bolukbas FF, Kendir T. The effectiveness of lamivudine treat- ment in cirrhotic patients with HBV precore mutations:a prospective[J]. open-label study,2006(7):120-121.
